Form 4: Astrana Health Officer Surrenders Shares for Tax Obligations

Sentiment:

SEC Form 4 Filing


Dinesh M. Kumar, Chief Medical Officer of Astrana Health Enablement of Nevada, Inc., surrendered 794 shares of common stock to cover tax withholding obligations.

Summary

  • On August 1, 2024, Dinesh M. Kumar, Chief Medical Officer of Astrana Health Enablement of Nevada, Inc., surrendered 794 shares of Astrana Health, Inc. common stock to satisfy tax withholding requirements.
  • The shares were surrendered at a price of $51.57 per share.
  • Following the transaction, Kumar directly owns 149,601 shares of Astrana Health, Inc.
  • Of these shares, 147,132 are restricted and will vest over several years, contingent upon continued employment and the achievement of performance goals.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (share surrender for tax obligations) and provides standard information about insider ownership. There are no indications of significant positive or negative developments.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard transaction related to tax obligations upon vesting of restricted stock.

Comparison to Industry Standards

  • Share surrenders for tax obligations are a common practice among publicly traded companies.
  • The vesting schedules outlined are typical for executive compensation packages, aligning with industry standards for incentivizing long-term performance and retention.
  • Comparable companies in the healthcare services sector, such as Oak Street Health (before its acquisition by CVS) or Agilon Health, also utilize restricted stock units with similar vesting schedules.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations related to executive compensation.

Key Dates

DateDescription
07/25/2024Date of Power of Attorney execution.
08/01/2024Date of share surrender transaction.
08/05/2024Date of Form 4 filing.
01/01/2025Start date for semi-annual vesting installments of some restricted shares.
01/23/2025Start date for annual vesting installments of some restricted shares.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.